Outsourcing a CNS or neurology program means sourcing CRO and CDMO partners who understand the blood-brain barrier, validated disease models (Alzheimer's, Parkinson's, epilepsy, ALS, MS, pain), CSF and PET biomarkers, behavioral and electrophysiology readouts, and CNS-experienced clinical sites and raters. On BioBridgeX, buyers compare qualified suppliers as the neutral marketplace, free for buyers, in one place.
CNS / Neurology CRO and CDMO vendors (141)
UNIQ Trials
Apeloa Pharmaceutical
TRiCBIO
VCHP Clinical Solutions
AAPharmaSyn
Famar Group
CDMO · Formulation Development, LNP / Delivery Formulation, Process Development
AbbVie Contract Manufacturing
CRO & CDMO · Drug Substance: Small Molecule / API, Drug Substance: Biologics, Formulation Development
Novocol Pharma
CDMO · Formulation Development, LNP / Delivery Formulation, Process Development
Kindeva Drug Delivery
CDMO · Formulation Development, LNP / Delivery Formulation, Process Development
Curia Global
CRO & CDMO · Drug Substance: Small Molecule / API, Drug Substance: Biologics, Formulation Development
Siegfried Holding
CRO & CDMO · Drug Substance: Small Molecule / API, Formulation Development, LNP / Delivery Formulation
Aenova Group
CDMO · Formulation Development, LNP / Delivery Formulation, Process Development
Vetter Pharma
CDMO · Formulation Development, LNP / Delivery Formulation, Process Development
Recipharm
CDMO · mRNA / RNA Manufacturing, LNP / Delivery Formulation, Drug Product Manufacturing
Phosphorex
CDMO · LNP / Delivery Formulation, Formulation Development, Process Development
Ascendia Pharmaceutical Solutions
CDMO · LNP / Delivery Formulation, Formulation Development, Drug Product Manufacturing
Agilent Technologies
CDMO · Peptide / Oligo Synthesis, Process Development, Analytical Development
Nitto Avecia Pharma Services
CDMO · Peptide / Oligo Synthesis, Process Development, Analytical Development
Ascend Advanced Therapies
CDMO · Viral Vector Manufacturing, Process Development, Analytical Development
PackGene Biotech
CRO & CDMO · Viral Vector Manufacturing, Plasmid DNA Manufacturing, mRNA / RNA Manufacturing
Viralgen (AskBio)
CDMO · Viral Vector Manufacturing, Process Development, Analytical Development
Andelyn Biosciences
CDMO · Viral Vector Manufacturing, Plasmid DNA Manufacturing, Process Development
Forge Biologics (Ajinomoto)
CDMO · Viral Vector Manufacturing, Plasmid DNA Manufacturing, Process Development
Oxford Biomedica
CDMO · Viral Vector Manufacturing, Plasmid DNA Manufacturing, Process Development
Catalent
CDMO · Viral Vector Manufacturing, Cell Therapy Manufacturing, Plasmid DNA Manufacturing
Polpharma Biologics
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Boehringer Ingelheim BioXcellence
CDMO · Cell Line / Strain Development, Process Development, Analytical Development
Teva API (TAPI)
CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
Almac Group
CRO & CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Onyx Scientific (IPCA)
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Laurus Labs (Laurus Synthesis)
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Navin Molecular (Navin Fluorine)
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
F.I.S. (Fabbrica Italiana Sintetici)
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
PROCOS
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Sumitomo Chemical (Pharmaceuticals/CDMO)
CDMO · Process Development, Drug Substance: Small Molecule / API, Analytical Development
Fermion (Orion Corporation)
CDMO · Process Development, Drug Substance: Small Molecule / API, Analytical Development
Minakem (Minafin Group)
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Curia (formerly AMRI)
CRO & CDMO · Target ID & Validation, Hit-to-Lead, Lead Optimization
Bachem
CDMO · Peptide / Oligo Synthesis, Process Development, Analytical Development
AMPAC Fine Chemicals (SK pharmteco)
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Veranova
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Pfizer CentreOne
CRO & CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
Noramco
CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
Thermo Fisher Scientific (Patheon)
CRO & CDMO · Process Development, Drug Substance: Small Molecule / API, Analytical Development
Divi's Laboratories
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Dr. Reddy's Custom Pharma Services (CPS)
CRO & CDMO · Process Development, Drug Substance: Small Molecule / API, Analytical Development
Piramal Pharma Solutions
CRO & CDMO · Hit-to-Lead, Lead Optimization, Medicinal & Synthetic Chemistry
EUROAPI
CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
Seqens
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Olon Group
CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
DOTTIKON ES
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Hovione
CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
CordenPharma
CRO & CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
Sterling Pharma Solutions
CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
WuXi STA (WuXi AppTec)
CRO & CDMO · Medicinal & Synthetic Chemistry, Process Development, Analytical Development
Asymchem
CRO & CDMO · Medicinal & Synthetic Chemistry, Process Development, Drug Substance: Small Molecule / API
Siegfried
CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
Cambrex
CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
Lonza
CRO & CDMO · Drug Substance: Small Molecule / API, Process Development, Analytical Development
Eurofins (Pharma Discovery & Bioanalytical Services)
CRO & CDMO · Bioanalytical Services, Central Laboratory Services, Genetic Toxicology
QPS Holdings
CRO · Bioanalytical Services, DMPK / ADME, GLP Toxicology
Simulations Plus
CRO · PK/PD & Modeling, DMPK / ADME, In Vitro / Early Toxicology
Certara
CRO · PK/PD & Modeling, Biostatistics & Statistical Programming, Medical Writing
Labcorp
CRO & CDMO · Central Laboratory Services, GLP Toxicology, Safety Pharmacology
Pharmacology Discovery Services (PDS)
CRO · In Vitro Pharmacology, Safety Pharmacology, Assay Development & Screening
InnoSer Laboratories
CRO · In Vitro Pharmacology, Biomarker Discovery & Development, PK/PD & Modeling
Hooke Laboratories
CRO · In Vitro Pharmacology, Biomarker Discovery & Development
GemPharmatech
CRO · In Vitro Pharmacology, Target ID & Validation, Biomarker Discovery & Development
Labcorp (Labcorp Drug Development)
CRO · In Vitro Pharmacology, DMPK / ADME, GLP Toxicology
WuXi AppTec (WuXi Biology)
CRO & CDMO · In Vitro Pharmacology, DMPK / ADME, Bioanalytical Services
The Jackson Laboratory (JAX)
CRO · In Vitro Pharmacology, Biomarker Discovery & Development, Target ID & Validation
BenevolentAI
CRO · Target ID & Validation, Computational / AI-Driven Discovery
Iktos
CRO · Hit-to-Lead, Lead Optimization, Medicinal & Synthetic Chemistry
Atomwise
CRO · Target ID & Validation, Hit-to-Lead, Computational / AI-Driven Discovery
Insilico Medicine
CRO · Target ID & Validation, Hit-to-Lead, Lead Optimization
Recursion Pharmaceuticals
CRO · Target ID & Validation, Assay Development & Screening, Hit-to-Lead
OpenEye, Cadence Molecular Sciences
CRO · Hit-to-Lead, Lead Optimization, Computational / AI-Driven Discovery
Cresset
CRO · Hit-to-Lead, Lead Optimization, Medicinal & Synthetic Chemistry
Schrodinger
CRO · Target ID & Validation, Hit-to-Lead, Lead Optimization
Hypha Discovery
CRO · Medicinal & Synthetic Chemistry, DMPK / ADME, Bioanalytical Services
ChemDiv
CRO · Assay Development & Screening, Hit-to-Lead, Lead Optimization
Enamine
CRO · Assay Development & Screening, Hit-to-Lead, Lead Optimization
Proteros Biostructures
CRO · Assay Development & Screening, Hit-to-Lead, Structural Biology
HitGen
CRO · Assay Development & Screening, Hit-to-Lead, Lead Optimization
X-Chem
CRO · Assay Development & Screening, Hit-to-Lead, Lead Optimization
Curia
CRO & CDMO · Target ID & Validation, Assay Development & Screening, Hit-to-Lead
BioDuro
CRO & CDMO · Target ID & Validation, Assay Development & Screening, Hit-to-Lead
Selvita
CRO · Target ID & Validation, Assay Development & Screening, Hit-to-Lead
Charnwood Discovery
CRO · Target ID & Validation, Assay Development & Screening, Hit-to-Lead
Domainex
CRO · Target ID & Validation, Assay Development & Screening, Hit-to-Lead
Sygnature Discovery
CRO · Target ID & Validation, Assay Development & Screening, Hit-to-Lead
Syngene International
CRO & CDMO · GLP Toxicology, Safety Pharmacology, DMPK / ADME
Aragen Life Sciences
CRO & CDMO · DMPK / ADME, GLP Toxicology, Safety Pharmacology
Sai Life Sciences
CRO & CDMO · DMPK / ADME, In Vitro / Early Toxicology, GLP Toxicology
JOINN Laboratories / Biomere
CRO · GLP Toxicology, Safety Pharmacology, Toxicokinetics (TK)
Lovelace Biomedical
CRO · GLP Toxicology, Safety Pharmacology, Toxicokinetics (TK)
Vivotecnia
CRO · GLP Toxicology, Safety Pharmacology, Genetic Toxicology
Nuvisan
CRO & CDMO · DMPK / ADME, Bioanalytical Services, In Vitro / Early Toxicology
Oncodesign Services
CRO · In Vitro Pharmacology, DMPK / ADME, Bioanalytical Services
Biotrial
CRO · Safety Pharmacology, GLP Toxicology, Toxicokinetics (TK)
Scantox
CRO · GLP Toxicology, Safety Pharmacology, Genetic Toxicology
Cyprotex (an Evotec company)
CRO · In Vitro / Early Toxicology, DMPK / ADME, Genetic Toxicology
Evotec
CRO & CDMO · In Vitro / Early Toxicology, DMPK / ADME, Safety Pharmacology
Reaction Biology
CRO · Assay Development & Screening, In Vitro Pharmacology, Target ID & Validation
Frontage Laboratories
CRO & CDMO · GLP Toxicology, Safety Pharmacology, Toxicokinetics (TK)
Eurofins Discovery
CRO · In Vitro / Early Toxicology, Safety Pharmacology, DMPK / ADME
WuXi AppTec
CRO & CDMO · GLP Toxicology, Safety Pharmacology, Genetic Toxicology
Inotiv
CRO · GLP Toxicology, Safety Pharmacology, Genetic Toxicology
Labcorp (Labcorp Drug Development / former Covance)
CRO & CDMO · GLP Toxicology, Safety Pharmacology, Genetic Toxicology
Charles River Laboratories
CRO & CDMO · GLP Toxicology, Safety Pharmacology, Genetic Toxicology
Avance Clinical
CRO · Clinical Operations, Phase 1 / Early Clinical Unit, Clinical Data Management
Cromos Pharma
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
George Clinical (Emerald Clinical)
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
TFS HealthScience
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Cytel
CRO · Biostatistics & Statistical Programming, Clinical Data Management, Clinical Operations
Precision for Medicine
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Pharmaron
CRO & CDMO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
WuXi Clinical
CRO · Clinical Operations, Phase 1 / Early Clinical Unit, Clinical Data Management
Tigermed
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
CMIC Group
CRO & CDMO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Linical
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Altasciences
CRO & CDMO · Phase 1 / Early Clinical Unit, Clinical Operations, Bioanalytical Services
Celerion
CRO · Phase 1 / Early Clinical Unit, Clinical Operations, Bioanalytical Services
ClinChoice
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Emmes
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
ProPharma
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Novotech
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Premier Research
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Veristat
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Caidya
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Allucent
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
PSI CRO
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
Worldwide Clinical Trials
CRO · Clinical Operations, Phase 1 / Early Clinical Unit, Clinical Data Management
Syneos Health
CRO · Clinical Operations, Phase 1 / Early Clinical Unit, Clinical Data Management
Medpace
CRO · Clinical Operations, Phase 1 / Early Clinical Unit, Clinical Data Management
Fortrea
CRO · Clinical Operations, Phase 1 / Early Clinical Unit, Clinical Data Management
PPD (Thermo Fisher Scientific)
CRO · Clinical Operations, Phase 1 / Early Clinical Unit, Clinical Data Management
Parexel
CRO · Clinical Operations, Phase 1 / Early Clinical Unit, Clinical Data Management
ICON plc
CRO · Clinical Operations, Phase 1 / Early Clinical Unit, Clinical Data Management
IQVIA
CRO · Clinical Operations, Clinical Data Management, Biostatistics & Statistical Programming
What kind of CRO work does a CNS / Neurology program need?
CNS and neurology programs carry a problem most other therapeutic areas do not: the brain is walled off. The blood-brain barrier keeps most molecules out, so the first questions a supplier has to answer are whether your compound actually crosses into the central compartment and how much of it reaches the target tissue, not just the plasma. That single fact reshapes the whole outsourcing plan, from the DMPK assays you run to the readouts you trust, and it is why a generalist tox lab that is excellent at oncology can be the wrong partner here.
In discovery and preclinical, the work clusters around brain exposure and the right models. You need DMPK that measures CNS penetration (brain-to-plasma ratios, unbound brain concentration via equilibrium dialysis, P-glycoprotein efflux liability, CSF sampling), efflux and transporter panels, and where relevant a microdialysis study to track free drug in the brain over time. The pharmacology runs in disease-relevant animal models that differ by indication: transgenic and amyloid or tau models for Alzheimer's, MPTP and alpha-synuclein models for Parkinson's, kindling and chemoconvulsant models for epilepsy, EAE for multiple sclerosis, SOD1 and other models for ALS, and a battery of pain and neuropathy assays. Readouts lean on behavioral testing (Morris water maze, rotarod, open field, fear conditioning), electrophysiology (EEG, patch-clamp, MEA), histopathology and neuroinflammation markers, and increasingly imaging such as small-animal PET or MRI. Safety pharmacology has a CNS-specific edge too, since seizure liability and the FOB or Irwin neurobehavioral screen sit right in the core battery.
On the clinical side, CNS trials are operationally hard in ways that show up in the supplier you pick. Endpoints are often subjective rating scales (ADAS-Cog, CDR-SB, UPDRS or MDS-UPDRS, EDSS, MADRS, seizure diaries), so rater training, certification, and central review become real line items, not afterthoughts. Placebo response runs high in CNS, which raises the bar on site selection and monitoring. Biomarkers matter enormously: CSF assays for amyloid, tau and p-tau, neurofilament light chain (NfL) as a neurodegeneration marker, and PET imaging with amyloid, tau, or dopamine-transporter tracers, all of which need a central lab and imaging core that have run these assays before. You will also source clinical operations, biostatistics with experience handling these scales, a central lab, imaging suppliers, pharmacovigilance, and clinical supply, often including formulation work for CNS delivery routes like intrathecal or intranasal administration. On the CDMO side, formulation and delivery for brain penetration (and for biologics, getting a large molecule past the barrier at all) is its own specialist conversation.
How do you choose a CRO for CNS / Neurology?
The deciding factor is genuine therapeutic-area depth, not a logo or the lowest bid. CNS is unforgiving of suppliers learning on your dime, because the models are finicky, the rating scales need trained hands, and a placebo-heavy trial punishes weak site selection. Score two or three candidates against the same written scope and weight the items below over headline price.
- Therapeutic-area experience: ask for completed programs in your specific indication (Alzheimer's, Parkinson's, epilepsy, ALS, MS, migraine, neuropathic pain, depression, schizophrenia), not just "CNS" in general. The right neurodegeneration model is different from the right epilepsy model.
- Relevant disease models and brain-exposure capability: confirm the in vivo model is already validated in-house with historical control data, and that they run CNS-specific DMPK (brain-to-plasma, unbound brain concentration, CSF sampling, P-gp efflux, microdialysis) rather than plasma PK alone.
- Biomarker and imaging access: for clinical work, check they can run or coordinate CSF biomarkers (amyloid, tau, p-tau, NfL) and PET or MRI imaging cores, with validated assays and harmonized reference ranges across sites.
- Rater training and endpoint quality: subjective scales (ADAS-Cog, UPDRS, EDSS, MADRS) live or die on rater certification and central review. Ask how they train, certify, and monitor raters to control variability and placebo response.
- Patient access and site network: CNS enrollment is slow, especially in rare neuromuscular and pediatric neurology indications. Confirm real access to qualified sites, investigators, and patient populations in your geographies, and a credible feasibility track record.
- Regulatory track record and data quality: ask for FDA, EMA, or PMDA inspection history, CDISC-conformant data delivery (SDTM and ADaM), and GLP status for pivotal safety work. Seizure liability and neurobehavioral findings draw reviewer scrutiny, so clean, defensible data matters.
- Capacity and turnaround: a strong lab booked solid can be slower than a good lab with an open slot. Pin down current queue, the named study director or project lead, milestone timelines, and how they handle change orders when a cohort fails or enrollment slips.
Frequently asked questions
Why are CNS and neurology trials considered harder to run than other therapeutic areas?
What CNS-specific DMPK work should I expect a preclinical CRO to run?
Which animal models matter for my CNS indication?
What biomarkers and imaging do CNS clinical trials rely on?
How do I control placebo response and rater variability in a CNS trial?
Can BioBridgeX source CNS suppliers across discovery, preclinical, and clinical in one place?
Source CNS / Neurology work with one contract
Compare transparent quotes from qualified CNS / Neurology CRO and CDMO vendors, then contract once. Free for buyers.
Compare quotes